Offer - Urjas Oil for just ₹ 1 X
Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate is an allopathic medicine The correct dosage of Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate is used -
Severe
Moderate
Mild
Common
Unknown
Is the use of Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate safe for pregnant women?
Pregnant women may experience moderate side effects from Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate. It is best to stop taking Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate immediately and inform your doctor if you notice any discomfort.
Is the use of Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate safe during breastfeeding?
In the absence of any scientific study about the side effects of Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate in breastfeeding women, information on safety of Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate is unavailable.
What is the effect of Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate on the Kidneys?
Using Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate does not have any harmful effects on kidneys.
What is the effect of Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate on the Liver?
Using Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate does not have any harmful effects on the liver.
What is the effect of Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate on the Heart?
There are no any side effects of Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate for the heart.
Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate unless your doctor advises you to do so -
Is this Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate habit forming or addictive?
Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate does not cause addiction.
Interaction between Food and Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate
Taking Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate with food does not harm your health.
Interaction between Alcohol and Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate
Information about the interaction of Cyclobenzaprine + Diclofenac + Menthol + Methyl Salicylate and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flexeril (cyclobenzaprine HCl)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 374-375
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 888